Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
    • COVID-19
      • Introduction
      • Science
      • Collaborators
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
  • Careers
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • All News
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

MD Anderson Cancer Center Joins ITUS Early Cancer Detection Biomarker Study

December 7, 2016

ITUS Announces Cchek(TM) Preliminary Cancer Patient Efficacy Study Results

December 7, 2016

ITUS Executive Chairman Dr. Amit Kumar Appointed to American Cancer Society National Board of Directors

November 30, 2016

ITUS Demonstrates Efficacy of its Cchek(TM) Early Cancer Detection Platform with 6 Additional Cancer Types

November 15, 2016

ITUS Demonstrates Efficacy of its Cchek(TM) Early Cancer Detection Platform with Pancreatic Cancer

October 25, 2016

ITUS Hires Michael Catelani as Chief Financial Officer

October 24, 2016

ITUS Receives Notice of NASDAQ Continued Listing Compliance

October 17, 2016

ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Thyroid Cancer

October 12, 2016

ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Liver Cancer

October 3, 2016

ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Ovarian Cancer

September 30, 2016

RSS
  • 1
  • 2
  • Next »

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Mar 4, 2021

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

Read More...
Feb 25, 2021

Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference

Read More...
Feb 16, 2021

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates

Read More...
Copyrights © 2021 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap